Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JEREMY B GREEN

Allopathic & Osteopathic Physicians Dermatology

NPI
1225249055
CMS profile
236822
Location
CORAL GABLES, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$75,698.34

65 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 2; records 51–65 of 65 matching records. This page contains 15 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JEREMY B GREEN

NPI 1225249055 · CMS profile ID 236822

Allopathic & Osteopathic Physicians / Dermatology

CORAL GABLES, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–65 of 65 matching records. This page contains 15 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1225249055?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JEREMY B GREEN, NPI 1225249055, CMS profile ID 236822. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–65 of 65 matching records. This page contains 15 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1225249055?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). JEREMY B GREEN, NPI 1225249055, CMS profile ID 236822. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–65 of 65 matching records. This page contains 15 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1225249055?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
JEREMY B GREEN, NPI 1225249055, CMS profile ID 236822, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–65 of 65 matching records. This page contains 15 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1225249055?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

65 matching records · $75,698.34 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 65 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–65 of 65.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $23.9905/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843758113 CMS
Galderma Laboratories, L.P. $18.9105/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855277239 CMS
MERZ NORTH AMERICA, INC. $7,830.0005/05/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 846663927 CMS
Allergan, Inc. $139.9004/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792788809 CMS
Biofrontera Inc. $14.3004/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795993011 CMS
Galderma Laboratories, L.P. $2,250.0004/20/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855277237 CMS
PFIZER INC. $18.4904/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832699121 CMS
UCB, Inc. $12.5404/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807337955 CMS
Galderma Laboratories, L.P. $9,375.0003/31/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855277233 CMS
Galderma Laboratories, L.P. $15,750.0003/31/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855277235 CMS
DERMIRA, INC. $24.7002/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 764403132 CMS
VYNE Pharmaceuticals Inc. $17.5702/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830829627 CMS
Galderma Laboratories, L.P. $6.9002/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855277231 CMS
PFIZER INC. $17.6801/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832671688 CMS
Regeneron Healthcare Solutions, Inc. $19.8901/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809582563 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $151,957.09 170
PY2020 $52,601.07 41
PY2021 $75,698.34 65
PY2022 $127,687.77 118
PY2023 $234,590.27 105
PY2024 $220,565.26 127
PY2025 $88,801.33 85

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $294,754.87 27
PY2024 Recipient $7,424.43 8
PY2024 Principal investigator $264,021.23 10
PY2023 Principal investigator $25,859.15 4
PY2022 Principal investigator $159,088.24 7
PY2021 Recipient $5,000.00 2
PY2021 Principal investigator $48,297.50 16
PY2020 Principal investigator $237,929.79 29
PY2019 Principal investigator $208,800.04 27

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

27 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $8,681.64 12/31/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
A Prospective, Open-Label Study to Evaluate Subject Satisfaction with Overall Facial Appearance After Treatment with JUVeDERM Products in Medical Weight Loss (MWL) Subjects No dispute reported 06/30/2026 1202533385
Principal investigator 1 ABBVIE INC. $9,166.68 12/31/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
A multicenter, evaluator and subject-blinded, randomized, comparator-controlled, parallel-design study to evaluate the safety and effectiveness of NOA VOLUME compared to JUVEDERM VOLUMA XC for improvement of mid-face volume No dispute reported 06/30/2026 1202533387
Principal investigator 1 ABBVIE INC. $127.45 12/31/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
A Phase 3 randomized, placebo-controlled, double-blind program to evaluate efficacy and safety of upadacitinib in adult and adolescent subjects with severe alopecia areata No dispute reported 06/30/2026 1202533389
Principal investigator 1 ABBVIE INC. $1,256.00 12/04/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202528428
Principal investigator 1 ABBVIE INC. $9,000.00 11/05/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
A Study to Evaluate the Safety and Effectiveness of JUVEDERM Products in Adult Participants for the Change of Their Overall Facial Appearance No dispute reported 06/30/2026 1202521365
Principal investigator 1 ABBVIE INC. $2,956.00 11/04/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202521235
Principal investigator 1 ABBVIE INC. $1,559.20 10/15/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study No dispute reported 06/30/2026 1202516995
Principal investigator 1 ABBVIE INC. $9,456.00 10/09/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202515857
Principal investigator 1 ABBVIE INC. $4,677.60 09/18/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study No dispute reported 06/30/2026 1202511580
Principal investigator 1 ABBVIE INC. $2,734.00 09/03/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202507881
Principal investigator 1 ABBVIE INC. $12,187.60 08/14/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study No dispute reported 06/30/2026 1202504813
Principal investigator 1 ABBVIE INC. $5,024.00 08/05/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202502234
Principal investigator 1 ABBVIE INC. $15,421.20 07/16/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study No dispute reported 06/30/2026 1202498408
Principal investigator 1 ABBVIE INC. $3,768.00 07/02/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202496695
Principal investigator 1 ABBVIE INC. $16,522.00 06/12/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study No dispute reported 06/30/2026 1202491261
Principal investigator 1 ABBVIE INC. $8,792.00 06/03/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202489885
Principal investigator 1 ABBVIE INC. $13,518.00 05/16/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study No dispute reported 06/30/2026 1202485293
Principal investigator 1 ABBVIE INC. $22,096.00 05/07/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202484133
Principal investigator 1 ABBVIE INC. $15,101.60 04/16/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study No dispute reported 06/30/2026 1202476977
Principal investigator 1 ABBVIE INC. $26,192.00 04/03/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202474326
Principal investigator 1 ABBVIE INC. $15,503.60 03/13/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-417 - BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study No dispute reported 06/30/2026 1202463679
Principal investigator 1 Galderma Laboratories, L.P. $9,290.00 03/12/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
Ultrasound visualization of morphological changes of hyaluronic acid filler in the infraorbital hollows No dispute reported 06/30/2026 1234513579
Principal investigator 1 ABBVIE INC. $37,058.50 03/07/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-841 - M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202462060
Principal investigator 1 ABBVIE INC. $18,918.40 02/13/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-417 - BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study No dispute reported 06/30/2026 1202451147
Principal investigator 1 ABBVIE INC. $536.50 02/06/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-841 - M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202449127
Principal investigator 1 ABBVIE INC. $22,290.40 01/16/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M21-417 - BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study No dispute reported 06/30/2026 1202439231
Principal investigator 1 ABBVIE INC. $2,920.50 01/02/2025 Non-covered Recipient Entity
SKIN RESEARCH INSTITUTE LLC
M23-716 - A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA) No dispute reported 06/30/2026 1202434319